{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:51:14Z","timestamp":1789541474127,"version":"build-2803163510"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"suppl_9","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI 108441"],"award-info":[{"award-number":["R01AI 108441"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI 042853"],"award-info":[{"award-number":["P30 AI 042853"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["N15-15-00050"],"award-info":[{"award-number":["N15-15-00050"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1093\/infdis\/jix408","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T18:39:25Z","timestamp":1505500765000},"page":"S816-S819","source":"Crossref","is-referenced-by-count":5,"title":["Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance"],"prefix":"10.1093","volume":"216","author":[{"given":"Catherine","family":"Godfrey","sequence":"first","affiliation":[{"name":"Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bobkova","sequence":"additional","affiliation":[{"name":"Ivanovsky Institute of Virology, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Boucher","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center, Department of Viroscience, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ravasi","sequence":"additional","affiliation":[{"name":"Pan American Health Organization\/World Health Organization"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[{"name":"China Office, Office of Global Research, NIAID, NIH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasong","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Treatment and Care, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Kantor","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Brown University Alpert Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"key\n\t\t\t\t20180306121631_CIT0001","volume-title":"HIV\/AIDS surveillance in Europe 2015","author":"European Centre for Disease Prevention and Control","year":"2015"},{"key":"key\n\t\t\t\t20180306121631_CIT0002","doi-asserted-by":"crossref","DOI":"10.1089\/aid.2017.0078","article-title":"Genetic variants of HIV type 1 in men who have sex with men in Russia","author":"Kazennova","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180306121631_CIT0003","volume-title":"State strategy to combat the spread of HIV in Russia through 2020 and beyond","author":"Government of Russia","year":"2016"},{"key":"key\n\t\t\t\t20180306121631_CIT0004","author":"Litvinova"},{"key":"key\n\t\t\t\t20180306121631_CIT0005","first-page":"3","article-title":"National recommendations on HIV treatment and care [in Russian]","volume":"6","author":"Pokrovsky","year":"2016","journal-title":"Epidemiol Infect Dis Topical Issues"},{"key":"key\n\t\t\t\t20180306121631_CIT0006","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(16)31480-5","article-title":"Gaps remain in Russia\u2019s response to HIV\/AIDS","volume":"388","author":"Clark","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121631_CIT0007","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12913-016-1601-5","article-title":"The epidemiology of tuberculosis in health care workers in South Africa: a systematic review","volume":"16","author":"Grobler","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"key\n\t\t\t\t20180306121631_CIT0008","doi-asserted-by":"crossref","first-page":"19506","DOI":"10.7448\/IAS.17.4.19506","article-title":"The cascade of HIV care in Russia, 2011\u20132013","volume":"17","author":"Pokrovskaya","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180306121631_CIT0009","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(11)60114-1","article-title":"Russia\u2019s drug-supply system leaves HIV patients wanting","volume":"377","author":"Parfitt","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121631_CIT0010","author":"Joint United Nations Programme on HIV\/AIDS"},{"key":"key\n\t\t\t\t20180306121631_CIT0011","volume-title":"Plan of action for the prevention and control of HIV and sexually transmitted infections 2016\u20132021","year":"2016"},{"key":"key\n\t\t\t\t20180306121631_CIT0012","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/S1020-49892011001200026","article-title":"Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean","volume":"30","author":"Ravasi","year":"2011","journal-title":"Rev Panam Salud Publica"},{"key":"key\n\t\t\t\t20180306121631_CIT0013","author":"Pan American Health Organization"},{"key":"key\n\t\t\t\t20180306121631_CIT0014","author":"Pan American Health Organization"},{"key":"key\n\t\t\t\t20180306121631_CIT0015","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1186\/s12889-015-2565-9","article-title":"Progress and challenges in implementing HIV care and treatment policies in Latin America following the treatment 2.0 initiative","volume":"15","author":"Perez","year":"2015","journal-title":"BMC Public Health"},{"key":"key\n\t\t\t\t20180306121631_CIT0016","author":"Pan American Health Organization"},{"key":"key\n\t\t\t\t20180306121631_CIT0017","author":"Joint United Nations Programme on HIV\/AIDS"},{"key":"key\n\t\t\t\t20180306121631_CIT0018","doi-asserted-by":"crossref","first-page":"e0158560","DOI":"10.1371\/journal.pone.0158560","article-title":"Surveillance of HIV transmitted drug resistance in Latin America and the Caribbean: a systematic review and meta-analysis","volume":"11","author":"Avila-Rios","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306121631_CIT0019","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jac\/dkw445","article-title":"Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15","volume":"72","author":"Bissio","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180306121631_CIT0020","doi-asserted-by":"crossref","first-page":"e0164156","DOI":"10.1371\/journal.pone.0164156","article-title":"HIV drug resistance in antiretroviral treatment-na\u00efve individuals in the largest public hospital in Nicaragua, 2011\u20132015","volume":"11","author":"Avila-R\u00edos","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306121631_CIT0021","volume-title":"China\u2019s anti-AIDS, HIV practices successful: experts","year":"2016"},{"key":"key\n\t\t\t\t20180306121631_CIT0022","author":"National Health and Family Planning Commission of the People\u2019s Republic of China"},{"key":"key\n\t\t\t\t20180306121631_CIT0023","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/1471-2334-12-382","article-title":"Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121631_CIT0024","doi-asserted-by":"crossref","first-page":"S300","DOI":"10.1093\/cid\/cir1018","article-title":"Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008","volume":"54","author":"Ma","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306121631_CIT0025","doi-asserted-by":"crossref","first-page":"e0166661","DOI":"10.1371\/journal.pone.0166661","article-title":"Drug resistance and virological failure among HIV-infected patients after a decade of antiretroviral treatment expansion in eight provinces of China","volume":"11","author":"Zuo","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306121631_CIT0026","doi-asserted-by":"crossref","first-page":"e110652","DOI":"10.1371\/journal.pone.0110652","article-title":"The prevalence of HIV-1 drug resistance among antiretroviral treatment na\u00efve individuals in mainland China: a meta-analysis","volume":"9","author":"Su","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306121631_CIT0027","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/vim.2014.0025","article-title":"Transmitted antiretroviral drug resistance in the men who have sex with men HIV patient cohort, Beijing, China, 2008\u20132011","volume":"27","author":"Dai","year":"2014","journal-title":"Viral Immunol"},{"key":"key\n\t\t\t\t20180306121631_CIT0028","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12981-015-0062-y","article-title":"Population-based human immunodeficiency virus 1 drug resistance profiles among individuals who experienced virological failure to first-line antiretroviral therapy in Henan, China during 2010\u20132011","volume":"12","author":"Liu","year":"2015","journal-title":"AIDS Res Ther"},{"key":"key\n\t\t\t\t20180306121631_CIT0029","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/aid.2013.0222","article-title":"Prevalence of drug resistance in human immunodeficiency virus type 1-infected treatment-naive children in Pune, India","volume":"30","author":"Kumar","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180306121631_CIT0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/aid.2015.0277","article-title":"Short communication: limited HIV pretreatment drug resistance among adults attending free antiretroviral therapy clinic of Pune, India","volume":"32","author":"Karade","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180306121631_CIT0031","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3851\/IMP2769","article-title":"Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India","volume":"19","author":"Neogi","year":"2014","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180306121631_CIT0032","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3851\/IMP1411","article-title":"Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India","volume":"14","author":"Vidya","year":"2009","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180306121631_CIT0033","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1086\/600044","article-title":"High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings","volume":"49","author":"Kumarasamy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306121631_CIT0034","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1089\/aid.2016.0110","article-title":"Genotypic HIV-1 drug resistance among patients failing tenofovir-based first-line HAART in south India","volume":"32","author":"Dinesha","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180306121631_CIT0035","doi-asserted-by":"crossref","first-page":"e4886","DOI":"10.1097\/MD.0000000000004886","article-title":"Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in western India","volume":"95","author":"Karade","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20180306121631_CIT0036","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s12879-015-1270-8","article-title":"Outcome of patients on second line antiretroviral therapy under programmatic condition in India","volume":"15","author":"Chakravarty","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306121631_CIT0037","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cid\/cir967","article-title":"Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India","volume":"54","author":"Saravanan","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306121631_CIT0038","first-page":"1","article-title":"Stigma, violence and HIV vulnerability among transgender persons in sex work in Maharashtra, India","author":"Ganju","year":"2017","journal-title":"Cult Health Sex"},{"key":"key\n\t\t\t\t20180306121631_CIT0039","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10461-010-9711-2","article-title":"The emerging HIV epidemic among men who have sex with men in Tamil Nadu, India: geographic diffusion and bisexual concurrency","volume":"14","author":"Solomon","year":"2010","journal-title":"AIDS Behav"},{"key":"key\n\t\t\t\t20180306121631_CIT0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/QAI.0000000000001372","article-title":"Injection drug network characteristics are important markers of HIV risk behavior and lack of viral suppression","volume":"75","author":"Cepeda","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180306121631_CIT0041","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2055-6640(20)31094-3","article-title":"India\u2019s HIV programme: successes and challenges","volume":"2","author":"Tanwar","year":"2016","journal-title":"J Virus Erad"},{"key":"key\n\t\t\t\t20180306121631_CIT0042","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/cid\/ciw001","article-title":"Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges","volume":"62","author":"Roberts","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306121631_CIT0043","doi-asserted-by":"crossref","first-page":"384805","DOI":"10.1155\/2013\/384805","article-title":"Entry, retention, and virological suppression in an HIV cohort study in India: description of the cascade of care and implications for reducing HIV-related mortality in low- and middle-income countries","volume":"2013","author":"Alvarez-Uria","year":"2013","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"key\n\t\t\t\t20180306121631_CIT0044","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1758-2652-13-35","article-title":"A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries","volume":"13","author":"Waning","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180306121631_CIT0045","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/09540121.2013.861573","article-title":"Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India","volume":"26","author":"Chakrapani","year":"2014","journal-title":"AIDS Care"},{"key":"key\n\t\t\t\t20180306121631_CIT0046","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/09540121.2012.672717","article-title":"The influence of stigma on HIV risk behavior among men who have sex with men in Chennai, India","volume":"24","author":"Thomas","year":"2012","journal-title":"AIDS Care"},{"key":"key\n\t\t\t\t20180306121631_CIT0047","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1472-6963-11-277","article-title":"High rates of adherence and treatment success in a public and public-private HIV clinic in India: potential benefits of standardized national care delivery systems","volume":"11","author":"Shet","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"key\n\t\t\t\t20180306121631_CIT0048","first-page":"257","article-title":"Continuing medical education on antiretroviral therapy in HIV\/AIDS in India: needs assessment and impact on clinicians and allied health personnel","volume":"22","author":"Kabra","year":"2009","journal-title":"Natl Med J India"},{"key":"key\n\t\t\t\t20180306121631_CIT0049","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/09540121003758531","article-title":"Health systems\u2019 responses to the roll-out of antiretroviral therapy (ART) in India: a comparison of two HIV high-prevalence settings","volume":"22","author":"Kudale","year":"2010","journal-title":"AIDS Care"},{"key":"key\n\t\t\t\t20180306121631_CIT0050","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/QAI.0b013e3182a6104a","article-title":"Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India","volume":"65","author":"Pujari","year":"2014","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"key\n\t\t\t\t20180306121631_CIT0051","volume-title":"HIV drug resistance surveillance guidance 2015 update","author":"World Health Organization","year":"2015"},{"key":"key\n\t\t\t\t20180306121631_CIT0052","volume-title":"Global Action Plan on HIV drug resistance 2017\u20132021","author":"World Health Organization","year":"2017"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_9\/S816\/24264772\/jix408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T19:24:17Z","timestamp":1602962657000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/suppl_9\/S816\/4159362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":52,"journal-issue":{"issue":"suppl_9","published-online":{"date-parts":[[2017,9,14]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix408","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11,15]]},"published":{"date-parts":[[2017,9,14]]}}}